NasdaqCM - Delayed Quote USD

Atossa Therapeutics, Inc. (ATOS)

1.4200 +0.0500 (+3.65%)
At close: April 22 at 4:00 PM EDT
1.4300 +0.01 (+0.70%)
After hours: April 22 at 7:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Expense
30,496.0000
27,691.0000
20,521.0000
14,607.0000
Operating Income
-30,496.0000
-27,691.0000
-20,521.0000
-14,607.0000
Net Non Operating Interest Income Expense
3,777.0000
877.0000
6.0000
-938.7940
Other Income Expense
-3,112.0000
-146.0000
-91.0000
-3,221.0000
Pretax Income
-29,831.0000
-26,960.0000
-20,606.0000
-17,828.0000
Net Income Common Stockholders
-29,831.0000
-26,960.0000
-20,606.0000
-22,331.0000
Diluted NI Available to Com Stockholders
-29,831.0000
-26,960.0000
-20,606.0000
-22,331.0000
Basic EPS
-0.24
-0.21
-0.18
-1.97
Diluted EPS
-0.24
-0.21
-0.18
-1.97
Basic Average Shares
126,414.0000
126,624.0000
116,950.0000
11,309.0000
Diluted Average Shares
126,414.0000
126,624.0000
116,950.0000
11,309.0000
Total Operating Income as Reported
-30,496.0000
-27,691.0000
-20,521.0000
-14,607.0000
Total Expenses
30,496.0000
27,691.0000
20,521.0000
14,607.0000
Net Income from Continuing & Discontinued Operation
-29,831.0000
-26,960.0000
-20,606.0000
-17,828.0000
Normalized Income
-26,841.0000
-26,960.0000
-20,606.0000
-14,556.0000
Interest Income
3,777.0000
877.0000
6.0000
--
Net Interest Income
3,777.0000
877.0000
6.0000
-938.7940
EBIT
-30,496.0000
-27,691.0000
-20,521.0000
-14,607.0000
EBITDA
-30,485.0000
-27,683.0000
-20,498.0000
-14,560.0000
Reconciled Depreciation
11.0000
8.0000
23.0000
47.0000
Net Income from Continuing Operation Net Minority Interest
-29,831.0000
-26,960.0000
-20,606.0000
-17,828.0000
Total Unusual Items Excluding Goodwill
-2,990.0000
--
--
-3,272.0000
Total Unusual Items
-2,990.0000
--
--
-3,272.0000
Normalized EBITDA
-27,495.0000
-27,683.0000
-20,498.0000
-11,288.0000
12/31/2020 - 11/8/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SLS SELLAS Life Sciences Group, Inc.
1.5400
0.00%
 
OCGN Ocugen, Inc.
1.2400
-6.06%
 
JAGX Jaguar Health, Inc.
0.1799
+14.66%
 
CTXR Citius Pharmaceuticals, Inc.
0.7342
-2.68%
 
ICU SeaStar Medical Holding Corporation
0.4358
+7.60%
 
VERU Veru Inc.
1.2700
-3.05%
 
TCON TRACON Pharmaceuticals, Inc.
1.8200
-7.14%
 
CADL Candel Therapeutics, Inc.
5.54
+7.16%
 
SNGX Soligenix, Inc.
0.4058
-5.85%
 
ATHE Alterity Therapeutics Limited
2.1300
+3.40%